Viewing Study NCT06346054



Ignite Creation Date: 2024-05-06 @ 8:20 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06346054
Status: RECRUITING
Last Update Posted: 2024-04-03
First Post: 2024-03-23

Brief Title: Molecular Assessment for Gastro-Esophageal Cancer
Sponsor: KU Leuven
Organization: KU Leuven

Study Overview

Official Title: Molecular Assessment for Gastro-Esophageal Cancer
Status: RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MAGEC
Brief Summary: The goal of this minimally invasive interventional study is to learn if oncometabolic biomarkers detected in the exhaled breath and blood can identify early-stage gastro-oesophageal cancer in patient at risk for gastro-oesophageal cancer

The main questions this study aims to answer

Are oncometabolites proficient and reproducible enough to function as diagnostic biomarkers Can these biomarkers identify early-stage gastro-esophageal cancer Researchers will compare participants with gastro-oesophageal cancer to healthy controls and participants with Barretts esophagus to detect meaningful differences between the groups

Participants will provide a breath and blood sample during their routine standard of care visits
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None